while in the swiftly evolving subject of most cancers therapeutics, being familiar with the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is very important for building efficient treatment plans. Among the most promising approaches is using in vitro bystander result assays, which Enjoy a pivotal job in maximizing therapeutic efficacy. The